Back to mobile site

More on CRBU

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+11.4% Growth)
- Ratings (8.2 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Caribou Bioscience, Inc (NQ:CRBU)
Delayed: 1.66 --0 (-0%)
Prev. Close $1.66  
Open$1.66 
52 Wk High$ 
52 Wk Low$ 
Day High$1.66 
Day Low$1.66 
P/E N/A  
EPS$ 
Volume307 

Friends, Peers and Foes (?): GTBP, LYEL, NRIX, SLS, CMPX (more...)

Jun 18, 2026 04:02 PM Form 8-K Caribou Biosciences, For: Jun 17
Jun 16, 2026 06:48 AM H.C. Wainwright Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU)
Jun 12, 2026 08:10 AM After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
Jun 11, 2026 08:03 AM Form 8-K Caribou Biosciences, For: Jun 11
Jun 11, 2026 08:02 AM Caribou reports long-term data for vispa-cel in lymphoma patients
Jun 11, 2026 08:01 AM Caribou Biosciences reports durable responses for CB-011 therapy
Jun 11, 2026 08:01 AM Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026
Jun 11, 2026 08:00 AM Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
Jun 5, 2026 04:01 PM Form DEFA14A Caribou Biosciences,
May 27, 2026 04:05 PM Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
View All Articles

Entities mentioned with CRBU

View All Entities